Penumbra Debt to Equity Ratio 2014-2020 | PEN
Current and historical debt to equity ratio values for Penumbra (PEN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Penumbra debt/equity for the three months ending June 30, 2020 was 0.12.
| Penumbra Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2020-06-30 | $0.07B | $0.62B | 0.12 |
| 2020-03-31 | $0.07B | $0.49B | 0.15 |
| 2019-12-31 | $0.07B | $0.49B | 0.15 |
| 2019-09-30 | $0.05B | $0.47B | 0.10 |
| 2019-06-30 | $0.05B | $0.45B | 0.10 |
| 2019-03-31 | $0.05B | $0.44B | 0.11 |
| 2018-12-31 | $0.00B | $0.42B | 0.00 |
| 2018-09-30 | $0.00B | $0.41B | 0.00 |
| 2018-06-30 | $0.00B | $0.43B | 0.00 |
| 2018-03-31 | $0.00B | $0.42B | 0.00 |
| 2017-12-31 | $0.00B | $0.40B | 0.00 |
| 2017-09-30 | $0.00B | $0.38B | 0.00 |
| 2017-06-30 | $0.00B | $0.37B | 0.00 |
| 2017-03-31 | $0.00B | $0.37B | 0.00 |
| 2016-12-31 | $0.00B | $0.27B | 0.00 |
| 2016-09-30 | $0.00B | $0.25B | 0.00 |
| 2016-06-30 | $0.00B | $0.25B | 0.00 |
| 2016-03-31 | $0.00B | $0.24B | 0.00 |
| 2015-12-31 | $0.00B | $0.23B | 0.00 |
| 2015-09-30 | $0.00B | $0.23B | 0.00 |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
| 2014-12-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | 0.00 | |
| 2013-12-31 | $0.01B | $-0.01B | -0.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.456B | $0.547B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $163.905B | 31.11 |
| Intuitive Surgical (ISRG) | United States | $80.262B | 72.12 |
| Edwards Lifesciences (EW) | United States | $47.837B | 42.74 |
| DexCom (DXCM) | United States | $42.194B | 145.45 |
| IDEXX Laboratories (IDXX) | United States | $32.470B | 72.17 |
| ALCON INC (ALC) | Switzerland | $30.239B | 33.85 |
| Olympus (OCPNY) | Japan | $26.047B | 67.86 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $25.615B | 16.51 |
| Hologic (HOLX) | United States | $17.753B | 26.57 |
| Teleflex (TFX) | United States | $17.374B | 34.27 |
| Varian Medical Systems (VAR) | United States | $15.785B | 43.46 |
| Sysmex ADR (SSMXY) | Japan | $15.570B | 0.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.875B | 0.00 |
| ABIOMED (ABMD) | United States | $14.002B | 83.55 |
| STERIS (STE) | Ireland | $13.101B | 26.96 |
| Masimo (MASI) | United States | $11.928B | 62.20 |
| SARTORIUS AG (SARTF) | Germany | $10.777B | 92.65 |
| Tandem Diabetes Care (TNDM) | United States | $6.343B | 0.00 |
| Globus Medical (GMED) | United States | $5.552B | 44.46 |
| Nevro (NVRO) | United States | $4.840B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $4.267B | 32.85 |
| Integra LifeSciences Holdings (IART) | United States | $4.080B | 18.71 |
| Wright Medical Group (WMGI) | Netherlands | $3.903B | 0.00 |
| OPKO Health (OPK) | United States | $3.771B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.950B | 29.86 |
| LivaNova (LIVN) | United Kingdom | $2.311B | 23.51 |
| Cantel Medical (CMD) | United States | $2.202B | 25.48 |
| Integer Holdings (ITGR) | United States | $2.134B | 16.16 |
| Glaukos (GKOS) | United States | $1.922B | 0.00 |
| ShockWave Medical (SWAV) | United States | $1.684B | 0.00 |
| Veracyte (VCYT) | United States | $1.636B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.577B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.489B | 33.48 |
| Luminex (LMNX) | United States | $1.486B | 139.39 |
| Mesa Laboratories (MLAB) | United States | $1.285B | 63.43 |
| GenMark Diagnostics (GNMK) | United States | $1.150B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.968B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.857B | 0.00 |
| CryoLife (CRY) | United States | $0.797B | 351.00 |
| Inogen (INGN) | United States | $0.770B | 81.16 |
| Pacific Biosciences Of California (PACB) | United States | $0.730B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.729B | 625.83 |
| Intersect ENT (XENT) | United States | $0.691B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.667B | 82.67 |
| Natus Medical (NTUS) | United States | $0.608B | 24.60 |
| Si-Bone (SIBN) | United States | $0.576B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.548B | 0.00 |
| Fluidigm (FLDM) | United States | $0.538B | 0.00 |
| AxoGen (AXGN) | United States | $0.486B | 0.00 |
| ViewRay (VRAY) | United States | $0.482B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.435B | 0.00 |
| Vermillion (AWH) | United States | $0.432B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.408B | 0.00 |
| Repro Med Systems (KRMD) | United States | $0.389B | 177.20 |
| TransMedics (TMDX) | United States | $0.386B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.363B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.355B | 104.78 |
| Semler Scientific (SMLR) | United States | $0.336B | 43.07 |
| IRadimed (IRMD) | United States | $0.268B | 50.95 |
| Accuray (ARAY) | United States | $0.236B | 0.00 |
| Sientra (SIEN) | United States | $0.210B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.203B | 0.00 |
| Restoration Robotics (VERO) | Canada | $0.098B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.095B | 46.86 |
| Spectral Diagnostics (EDTXF) | Canada | $0.092B | 0.00 |
| Neuronetics (STIM) | United States | $0.066B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.066B | 0.00 |
| MRI Interventions (CLPT) | United States | $0.062B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.056B | 0.00 |
| ConforMIS (CFMS) | United States | $0.055B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.052B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.051B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.050B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.049B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.043B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.042B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.036B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.031B | 0.00 |
| Neovasc (NVCN) | Canada | $0.030B | 0.00 |
| Avinger (AVGR) | United States | $0.029B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.025B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.022B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.021B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.016B | 0.00 |
| Dynatronics (DYNT) | United States | $0.013B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.009B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.009B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.007B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.006B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.005B | 0.00 |
